$2.86
0.4418.18%
Last update: Oct 6, 7:48 PM
$2.64
0.229.09%
Jupiter Neurosciences Inc (JUNS) Stock Price, Quote, News & History
JUNSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Jupiter Neurosciences (NASDAQ:JUNS) through any online brokerage.
Other companies in Jupiter Neurosciences’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Jupiter Neurosciences to provide a consensus price target.
The stock price for Jupiter Neurosciences (NASDAQ: JUNS) is $2.64 last updated October 6, 2026 at 7:48 PM EDT.
There are no upcoming dividends for Jupiter Neurosciences.
Jupiter Neurosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Jupiter Neurosciences.
Jupiter Neurosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol,...
